(2~{R},3~{R},5~{S},6~{E},8~{E},10~{Z},12~{S},13~{R},16~{Z},18~{E},20~{Z},22~{E},24~{R},25~{S},26~{E},28~{Z})-13-[(2~{S},3~{S},5~{S})-3,5-bis(oxidanyl)hexan-2-yl]-25-[(2~{R},3~{R},4~{S},5~{R},6~{R})-3,4-dimethoxy-6-methyl-5-oxidanyl-oxan-2-yl]oxy-3-methoxy-2,12,22,24-tetramethyl-5-oxidanyl-14,32-dioxa-33-azabicyclo[28.2.1]tritriaconta-1(33),6,8,10,16,18,20,22,26,28,30-undecaen-15-one
P68135 — Actin, alpha skeletal muscle
ECOD Domain Annotations
ECOD domains from AlphaFold model interacting with ligand CV9
| UniProt | DrugBank | PDB Ligand | Domain Label | ECOD ID | X Group | H Group | T Group | F Group |
|---|---|---|---|---|---|---|---|---|
| No predicted ECOD data found | ||||||||
ECOD domains from experimental PDB structures interacting with ligand CV9
| UniProt | DrugBank | PDB ID | Ligand Acc. | Chain | Res No. | Exp. Domain | X Group | H Group | T Group | F Group |
|---|---|---|---|---|---|---|---|---|---|---|
| P68135 | n/a | 6qri | CV9 | A | 403 | e6qriA1 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | A | 403 | e6qriA2 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | A | 403 | e6qriB1 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | A | 403 | e6qriB2 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | B | 403 | e6qriA1 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | B | 403 | e6qriA2 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | B | 403 | e6qriB1 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |
| P68135 | n/a | 6qri | CV9 | B | 403 | e6qriB2 | Ribonuclease H-like | Ribonuclease H-like | Ribonuclease H-like | Actin |